Kodak, the fallen giant of the photography industry, is pivoting to make the ingredients used in generic drugs to fight coronavirus.
The Trump administration on Tuesday said it was extending a $765m loan to Kodak, as the US government tries to expand domestic manufacturing across medical supply chains to reduce dependence on foreign countries, particularly China.
Kodak will produce both “starting materials” and active pharmaceutical ingredients, White House trade adviser Peter Navarro said in a Fox Business interview on Tuesday.
您已閱讀16%（532字），剩餘84%（2697字）包含更多重要資訊，訂閱以繼續探索完整內容，並享受更多專屬服務。